Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ave1625
1. 358970-97-5
2. Ave-1625
3. Ave1625
4. Drinabant [inn]
5. Ave 1625
6. 61s98rll5i
7. N-[1-[bis(4-chlorophenyl)methyl]azetidin-3-yl]-n-(3,5-difluorophenyl)methanesulfonamide
8. N-(1-(bis(4-chlorophenyl)methyl)azetidin-3-yl)-n-(3,5-difluorophenyl)methanesulfonamide
9. Unii-61s98rll5i
10. Drinabant [who-dd]
11. Schembl684143
12. Chembl3545166
13. Dtxsid50189455
14. Zinc59299699
15. Hy-14788
16. Cs-0003562
17. 970d975
18. Q5307675
19. Methanesulfonamide, N-(1-(bis(4-chlorophenyl)methyl)-3-azetidinyl)-n-(3,5-difluorophenyl)-
20. N-[1-[bis(4-chlorophenyl)methyl]-3-azetidinyl]-n-(3,5-difluorophenyl)methanesulfonamide
| Molecular Weight | 497.4 g/mol |
|---|---|
| Molecular Formula | C23H20Cl2F2N2O2S |
| XLogP3 | 5.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 496.0590608 g/mol |
| Monoisotopic Mass | 496.0590608 g/mol |
| Topological Polar Surface Area | 49 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 686 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in alzheimer's disease, obesity, and schizophrenia and schizoaffective disorders.
AVE-1625 is a selective and potent antagonist of cannabinoid 1 (CB1) receptors having the same mechanism of action as rimonabant.
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
69
PharmaCompass offers a list of Drinabant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Drinabant manufacturer or Drinabant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Drinabant manufacturer or Drinabant supplier.
PharmaCompass also assists you with knowing the Drinabant API Price utilized in the formulation of products. Drinabant API Price is not always fixed or binding as the Drinabant Price is obtained through a variety of data sources. The Drinabant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Drinabant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Drinabant, including repackagers and relabelers. The FDA regulates Drinabant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Drinabant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Drinabant supplier is an individual or a company that provides Drinabant active pharmaceutical ingredient (API) or Drinabant finished formulations upon request. The Drinabant suppliers may include Drinabant API manufacturers, exporters, distributors and traders.
Drinabant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Drinabant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Drinabant GMP manufacturer or Drinabant GMP API supplier for your needs.
A Drinabant CoA (Certificate of Analysis) is a formal document that attests to Drinabant's compliance with Drinabant specifications and serves as a tool for batch-level quality control.
Drinabant CoA mostly includes findings from lab analyses of a specific batch. For each Drinabant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Drinabant may be tested according to a variety of international standards, such as European Pharmacopoeia (Drinabant EP), Drinabant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Drinabant USP).
